05/09/2024 7:00 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 7:30 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 8:17 AM | Corbus Pharmaceuticals (Issuer) Moran Sean F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:58 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 3:59 PM | Corbus Pharmaceuticals (Filer)
| Form DEFA14A | |
03/22/2024 4:05 PM | Corbus Pharmaceuticals (Filer)
| Form PRE 14A | |
03/20/2024 11:15 PM | Corbus Pharmaceuticals (Filer)
| Form EFFECT | |
|
03/20/2024 4:07 PM | Corbus Pharmaceuticals (Filer)
| Form 424B3 | |
03/20/2024 4:10 PM | Corbus Pharmaceuticals (Filer)
| Form 10-K/A | |
03/20/2024 4:13 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 3:52 PM | Corbus Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/12/2024 4:19 PM | Corbus Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/12/2024 7:15 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 4:34 PM | Chen Bihua (Reporting) Corbus Pharmaceuticals (Issuer) Cormorant Asset Management, LP (Reporting) Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:13 PM | Corbus Pharmaceuticals (Issuer) Smethurst Dominic (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:07 PM | Corbus Pharmaceuticals (Issuer) Smethurst Dominic (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
02/14/2024 3:45 PM | Corbus Pharmaceuticals (Subject) K2 HealthVentures Equity Trust LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 2:19 PM | Cohen Yuval (Reporting) Corbus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 2:26 PM | Corbus Pharmaceuticals (Issuer) Moran Sean F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 3:47 PM | Corbus Pharmaceuticals (Subject) Cormorant Global Healthcare Master Fund, LP (Filed by)
| Form SC 13G | |
02/05/2024 7:12 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/01/2024 7:55 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K/A | |
02/01/2024 4:27 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/01/2024 4:09 PM | Corbus Pharmaceuticals (Filer)
| Form 424B5 | |
01/31/2024 8:16 AM | Corbus Pharmaceuticals (Filer)
| Form S-3MEF | |
01/30/2024 7:40 PM | Corbus Pharmaceuticals (Filer)
| Form 424B5 | |
01/30/2024 7:41 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/30/2024 5:07 PM | Corbus Pharmaceuticals (Issuer) HOLMER ALAN F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:56 PM | Cohen Yuval (Reporting) Corbus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:18 PM | Chen Bihua (Reporting) Corbus Pharmaceuticals (Issuer) Cormorant Asset Management, LP (Reporting) Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/30/2024 3:23 PM | Chen Bihua (Reporting) Corbus Pharmaceuticals (Issuer) Cormorant Asset Management, LP (Reporting) Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 3:40 PM | Corbus Pharmaceuticals (Subject) Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
01/29/2024 6:30 AM | Corbus Pharmaceuticals (Filer)
| Form 424B3 | |
01/29/2024 6:31 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 7:45 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 4:25 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 3:57 PM | Corbus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 8:23 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 4:21 PM | Corbus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023 8:05 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 7:44 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Biden to Drop BOMBSHELL June 13th? (Ad) Biden’s days are numbered!
According to a former CIA and Pentagon insider…
He’s about to drop out of the presidential race on June 13th! Click here now to see his shocking evidence. |
06/13/2023 11:15 PM | Corbus Pharmaceuticals (Filer)
| Form EFFECT | |
06/13/2023 3:58 PM | Corbus Pharmaceuticals (Filer)
| Form 424B3 | |
06/12/2023 3:53 PM | Corbus Pharmaceuticals (Filer)
| Form S-3/A | |
05/31/2023 8:05 PM | Corbus Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
05/22/2023 3:32 PM | Corbus Pharmaceuticals (Issuer) Jenkins John Kenneth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2023 3:33 PM | Altmeyer Anne (Reporting) Corbus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2023 3:17 PM | CATLIN AVERY W (Reporting) Corbus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2023 3:20 PM | Ben Yong (Reporting) Corbus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2023 3:22 PM | Corbus Pharmaceuticals (Issuer) HOLMER ALAN F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2023 3:24 PM | Corbus Pharmaceuticals (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 8:01 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |